ARQT – arcutis biotherapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting [Yahoo! Finance]
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $13.00 to $15.00. They now have a "neutral" rating on the stock.
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its price target raised by analysts at Mizuho from $20.00 to $21.00. They now have an "outperform" rating on the stock.
Form S-8 Arcutis Biotherapeutics,
Form 10-K Arcutis Biotherapeutics, For: Dec 31
Form 8-K Arcutis Biotherapeutics, For: Feb 25
Form 4 Arcutis Biotherapeutics, For: Feb 03 Filed by: Matsuda Masaru
Form 4 Arcutis Biotherapeutics, For: Feb 03 Filed by: Watanabe Todd Franklin
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.